Anvisa approves new drug to treat bladder cancer
The National Agency of Sanitary Surveillance (Anvisa) approved on Monday (20) a new medicine for treatment of bladder cancer for patients in stage advanced disease and also for those who have not had results with platinum-based chemotherapy.
The drug is Keytruda (pembrolizumab), the anti-PD-1 immunotherapy manufactured by the pharmaceutical MSD, used for the treatment of various types of tumors. To achieve the result that the remedy actually works in patients with bladder cancer, analyzes were performed with 542 patients undergoing treatment with pembrolizumab or placebo. chemotherapy. This study was called phase III, Keynote-045.
According to the laboratory, in the 22.5-month study, pembrolizumab treatment was 30% more effective than chemotherapy. In addition, the side effects were minor.
Bladder cancer is a type of cancer that starts in the cells lining the bladder. According to the National Cancer Institute, it is estimated that almost 10,000 new cases of the disease appear every year, with the majority being male.
Decent teeth usually start appearing when your baby is between 6 months and one year old. Primary teeth help children chew and talk. They also maintain the space in the jaw and jaw for permanent teeth that are developing below the gums. Most children have a complete set of 20 deciduous teeth until they are 3 years old.
The feeling of tired legs can have different causes. The nuisance can, in many cases, be a symptom of poor circulation in the region. Some poor habits can cause and aggravate circulation problems in the legs and therefore avoiding them helps to alleviate the problem. "The best way to mitigate the symptoms of lower limb varicose veins is to combat sedentary lifestyle and obesity through supervised physical activity and a balanced diet, "says Marcos Arêas Marques, an assistant professor at the University Hospital Pedro Ernesto and a member of the Scientific Council of the Brazilian Society of Angiology and Vascular Surgery (SBACV).